Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages

  Choke, Edward ^a   Cockerill, Gillian W ^a   Dawson, Joseph ^a   Howe, Franklyn ^a   Wilson, William R W ^a   Loftus, Ian M ^a   Thompson, Matthew M ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; GELATINASE A; RECOMBINANT VASCULOTROPIN;

ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; AORTA; AORTA WALL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GENE EXPRESSION; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT INDICATION; UPREGULATION;

EID: 77953684617     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.015     Document Type: Article

References (33)

1. Choke E., Cockerill G., Wilson W.R., Sayed S., Dawson J., Loftus I., et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30 (2005) 227-244
2. Thompson M.M., Jones L., Nasim A., Sayers R.D., and Bell P.R. Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 11 (1996) 464-469
3. Kobayashi M., Matsubara J., Matsushita M., Nishikimi N., Sakurai T., and Nimura Y. Expression of angiogenesis and angiogenic factors in human aortic vascular disease. J Surg Res 106 (2002) 239-245
4. Holmes D.R., Liao S., Parks W.C., and Thompson R.W. Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg 21 (1995) 761-771
5. Choke E., Thompson M.M., Dawson J., Wilson W.R., Sayed S., Loftus I.M., et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 26 (2006) 2077-2082
6. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21 (2001) 1104-1117
7. Tedesco M.M., Terashima M., Blankenberg F.G., Levashova Z., Spin J.M., Backer M.V., et al. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol 29 (2009) 1452-1457
8. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., and Stanley J.C. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13 (1991) 452-458
9. Wilson W.R., Anderton M., Schwalbe E.C., Jones J.L., Furness P.N., Bell P.R., et al. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 113 (2006) 438-445
10. Chaabane L., Soulas E.C., Contard F., Salah A., Guerrier D., Briguet A., et al. High-resolution magnetic resonance imaging at 2 Tesla: potential for atherosclerotic lesions exploration in the apolipoprotein E knockout mouse. Invest Radiol 38 (2003) 532-538
11. Hockings P.D., Roberts T., Galloway G.J., Reid D.G., Harris D.A., Vidgeon-Hart M., et al. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation 106 (2002) 1716-1721
12. Choudhury R.P., Aguinaldo J.G., Rong J.X., Kulak J.L., Kulak A.R., Reis E.D., et al. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis 162 (2002) 315-321
13. Chaabane L., Canet E., Serfaty J.M., Contard F., Guerrier D., Douek P., et al. Microimaging of atherosclerotic plaque in animal models. MAGMA 11 (2000) 58-60
14. Fayad Z.A., Fallon J.T., Shinnar M., Wehrli S., Dansky H.M., Poon M., et al. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 98 (1998) 1541-1547
15. Marjamaa J., Tulamo R., Abo-Ramadan U., Hakovirta H., Frosen J., Rahkonen O., et al. Mice with a deletion in the first intron of the Col1a1 gene develop dissection and rupture of aorta in the absence of aneurysms: high-resolution magnetic resonance imaging, at 4.7 T, of the aorta and cerebral arteries. Magn Reson Med 55 (2006) 592-597
16. McFadden E.P., Chaabane L., Contard F., Guerrier D., Briguet A., Douek P., et al. In vivo magnetic resonance imaging of large spontaneous aortic aneurysms in old apolipoprotein E-deficient mice. Invest Radiol 39 (2004) 585-590
17. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105 (2000) 1605-1612
18. Saraff K., Babamusta F., Cassis L.A., and Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23 (2003) 1621-1626
19. Barisione C., Charnigo R., Howatt D.A., Moorleghen J.J., Rateri D.L., and Daugherty A. Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. J Vasc Surg 44 (2006) 372-376
20. Wang Y., Cassis L., and Daugherty A. Angiotensin II-induced aortic aneurysms. In: Xu Q. (Ed). A handbook of mouse models of cardiovascular diseases (2006), John Wiley and Sons Ltd, New York 125-135
21. Unemori E.N., Ferrara N., Bauer E.A., and Amento E.P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153 (1992) 557-562
22. Zucker S., Mirza H., Conner C.E., Lorenz A.F., Drews M.H., Bahou W.F., et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 75 (1998) 780-786
23. Chan V.T., Zhang D.N., Nagaravapu U., Hultquist K., Romero L.I., and Herron G.S. Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: expression and morphogenetic correlation. J Invest Dermatol 111 (1998) 1153-1159
24. Lamoreaux W.J., Fitzgerald M.E., Reiner A., Hasty K.A., and Charles S.T. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 55 (1998) 29-42
25. Heissig B., Rafii S., Akiyama H., Ohki Y., Sato Y., Rafael T., et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med 202 (2005) 739-750
26. Wang H. Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83 (1998) 832-840
27. Pepper M.S., Rosnoblet C., Di Sanza C., and Kruithof E.K. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells. Thromb Haemost 86 (2001) 702-709
28. Sahni A., Sahni S.K., Simpson-Haidaris P.J., and Francis C.W. Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. J Thromb Haemost 2 (2004) 1629-1636
29. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., and Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276 (2001) 7614-7620
30. Stannard A.K., Khurana R., Evans I.M., Sofra V., Holmes D.I., and Zachary I. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 27 (2007) 494-502
31. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
32. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
33. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7 (2001) 425-429